メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
富山大学 ホーム
日本語
English
ホーム
プロファイル
研究部門
設備
プロジェクト
研究成果
データセット
受賞
活動
コース
専門知識、名前、または所属機関で検索
医師キャリアパス創造センター
富山大学
医学系
概要
フィンガープリント
ネットワーク
研究成果
(57)
データセット
(11)
フィンガープリント
医師キャリアパス創造センターが活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Transient Receptor Potential Vanilloid 4 (TRPV4)
100%
Advanced Gastric Cancer
66%
Cisplatin
52%
Fluoropyrimidine
41%
Acute Abdomen
40%
Primary Care
40%
Practice Guidelines
40%
Irinotecan
37%
Ulcer
33%
ATP Release
32%
Docetaxel
30%
S-1 Plus Cisplatin
28%
Keratinocytes
28%
Vanilloid
27%
TRP Channels
27%
Stomach
27%
Second-line Chemotherapy
27%
Adenosine Triphosphate Production
26%
Mitomycin C
26%
Duodenal Ulcer
26%
Gastric Epithelium
26%
Calcium Influx
26%
Infliximab
26%
Ulcerative Colitis
26%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
25%
Diarrhea
24%
Differential Diagnosis
23%
Intestinal Epithelium
22%
Gastrointestinal
20%
Helicobacter Pylori (H. pylori)
20%
Risk Factors
20%
Chemotherapy-induced Diarrhea
20%
Protein-losing Enteropathy
20%
Colorectal Cancer
20%
Monotherapy
20%
Amrubicin
20%
Older Men
19%
Inflammatory Bowel Disease
19%
Exocytosis
18%
Adenosine Triphosphate
18%
Pancreatitis
16%
5-fluorouracil (5-FU)
16%
Gastric Emptying
16%
Gastrointestinal Cancer
16%
Drug Use
15%
Combination Chemotherapy
15%
Phase II Study
15%
Neuroendocrine Carcinoma
15%
Intestinal mucosal Injury
15%
Median Progression-free Survival
14%
Acute Pancreatitis
14%
Vesicular nucleotide Transporter
14%
Nonerosive Reflux Disease
14%
Ion Channels
14%
Inhibitory Motor Neurons
14%
Constipation
13%
Drug-induced
13%
Portal Thrombosis
13%
TJ-68
13%
CagA Protein
13%
Chronic Inflammation
13%
Non-randomized Comparison
13%
Baroreception
13%
Novel Therapeutic Targets
13%
Self-assessment Questionnaire
13%
Medical Knowledge
13%
Medical Skills
13%
IgA Vasculitis (IgAV)
13%
High Molecular Weight
13%
Cell-Associated
13%
Interstitial Lung Disease
13%
Japanese Patients
13%
Blood Pressure
13%
Clinical Clerkship
13%
Endoscopic Papillectomy
13%
Gastric Neuroendocrine Carcinoma
13%
Recurrent Lesions
13%
Pulmonary Involvement
13%
Shakuyakukanzoto
13%
Non-invasive Method
13%
Extraintestinal Manifestations
13%
Kampo Medicine
13%
Kampo
13%
Lupus Erythematosus
13%
Healing Process
13%
National Database
13%
Nitric Oxide Production
13%
Nivolumab
13%
Intra-aortic Balloon Occlusion
13%
Gastric Adaptive Relaxation
13%
Duodenal Stenosis
13%
Clear Cell
13%
Cystic Duct
13%
Glucose Clearance
13%
Gastrointestinal Stromal Tumor
13%
Thermosensitive
13%
3-channel
13%
Transient Receptor Potential vanilloid-3
13%
Oral Epithelium
13%
Crohn's Disease
13%
Medicine and Dentistry
Vanilloid Receptor 4
80%
Adenosine Triphosphate
60%
Primary Health Care
40%
Acute Abdomen
40%
Ulcer
35%
Keratinocyte
28%
Vanilloid Receptor
27%
Calcium Transport
26%
Abdominal Cancer
26%
Ulcerative Colitis
26%
Endoscopy
25%
Differential Diagnosis
21%
Helicobacter Pylori
21%
Protein Losing Enteropathy
20%
Constipation
20%
Gastrointestinal Epithelium
19%
Neoplasm
18%
Exocytosis
17%
Duodenum Ulcer
16%
Stomach Emptying
16%
Immunity
16%
Nonsteroid Antiinflammatory Agent
15%
Ion Channel
15%
Fluoropyrimidine
15%
Proton-Pump Inhibitor
14%
Nucleotide Transporter
14%
Nitric Oxide
14%
Duodenum
14%
Nivolumab
13%
Arm
13%
Endoscopic Papillotomy
13%
Gastrointestinal Stromal Tumor
13%
Non Invasive Procedure
13%
CagA Protein
13%
Jejunum
13%
Kampo
13%
Self-Diagnosis
13%
Non Erosive Reflux Disease
13%
Mitomycin
13%
Chronic Inflammation
13%
Duodenal Ulcer Bleeding
13%
Pancreatitis
13%
Irinotecan
13%
Interstitial Lung Disease
13%
Magnifying Endoscopy
13%
Medical Student
13%
Endoscopic Retrograde Cholangiopancreatography
13%
Reflux Esophagitis
13%
Blood Pressure
13%
Portal Vein Thrombosis
13%
Conservative Treatment
13%
Balloon Occlusion
13%
Cystic Duct
13%
Endoscopic Hemostasis
13%
Myenteric Plexus
13%
Lymphoma
13%
Immunoblotting
13%
Soluble Interleukin 2 Receptor
13%
Vanilloid Receptor 3
13%
Duodenum Stenosis
13%
DNA Mismatch Repair
13%
Epitope
13%
Colon Ulcer
13%
Endoscopic Ultrasound Guided Fine Needle Biopsy
13%
Clear Cell
13%
Cholangiocarcinoma
13%
Transitional Cell Carcinoma
13%
Intestine Injury
13%
Endoscopic Submucosal Dissection
13%
Retrospective Study
13%
Lymph Node Metastasis
13%
Down Syndrome
13%
Proteinase Activated Receptor 2
13%
Cell Transformation
13%
Wound Healing
13%
Gastrointestinal Tumor
13%
Lupus Vulgaris
13%
Antihypertensive
13%
Drug Use
13%
Infliximab
13%
Salivation
11%
Diarrhea
11%
Proctocolectomy
10%
Laxative
10%
Messenger RNA
10%
Colorectal Carcinoma
10%
Computer Assisted Tomography
10%
Methylation
10%
Adenocarcinoma
9%
Gastroesophageal Reflux
9%
Capsule Endoscopy
9%
Bleeding
9%
Calcium Ion
9%
Pyoderma gangrenosum
8%
Disease Predisposition
8%
Pulmonary Infiltrate
8%
Prednisolone
8%
Lung
8%
Koji
8%
Vasodilator Agent
8%
Pharmacology, Toxicology and Pharmaceutical Science
Vanilloid Receptor 4
80%
Adenosine Triphosphate
58%
Abdominal Cancer
53%
Cisplatin
50%
Chemotherapy
47%
Fluoropyrimidine
41%
Acute Abdomen
40%
Irinotecan
33%
Diarrhea
32%
Docetaxel
28%
Mitomycin
26%
Neuroendocrine Carcinoma
26%
Infliximab
26%
Constipation
23%
Second-Line Chemotherapy
23%
Inflammatory Bowel Disease
19%
Injury
16%
Acute Pancreatitis
16%
Monotherapy
16%
Amrubicin
16%
Pancreatitis
15%
Fluorouracil
15%
Nucleotide Transporter
14%
Vanilloid Receptor
14%
Overall Survival
13%
Crohn's Disease
13%
CagA Protein
13%
Chronic Inflammation
13%
Immunoglobulin A
13%
Retrospective Study
13%
Mercaptopurine
13%
Tumor Necrosis Factor Inhibitor
13%
Digestive System Cancer
13%
Vasculitis
13%
Kampo Medicine (Drug)
13%
Portal Vein Thrombosis
13%
Esophageal Squamous Cell Carcinoma
13%
Protein Losing Gastroenteropathy
13%
Down Syndrome
13%
Nitric Oxide
13%
Nedaplatin
13%
Proteinase Activated Receptor 2
13%
Vanilloid Receptor 3
13%
CagA
13%
Intestine Injury
13%
Paclitaxel
13%
Indometacin
13%
Wound Healing
13%
Ramucirumab
13%
Lupus Vulgaris
13%
Koji
13%
Antihypertensive
13%
Ulcerative Colitis
13%
Adverse Event
12%
Progression Free Survival
11%
Adalimumab
10%
Laxative
10%
Non-Steroidal Anti-Inflammatory Drug
10%
Knockout Mouse
10%
Anemia
9%
Neutropenia
9%
Calcium Ion
9%
Western Blot
9%
Disease Predisposition
8%
Clinical Trial
8%
Normal Human
8%
Vasodilator Agent
8%
Clodronic Acid
7%
Messenger RNA
7%
Maximum Tolerated Dose
7%
Capecitabine Plus Oxaliplatin
6%
Jaundice
6%
Liver Metastasis
6%
Epitope
6%
Retina Detachment
6%
Tumor Necrosis Factor
6%
Mitogen Activated Protein Kinase Kinase Inhibitor
6%
Colorectal Carcinoma
6%
Irritable Colon
6%
Diseases
6%
Autoimmune Disease
5%
Gastroesophageal Reflux
5%
Wild Type Mouse
5%
Purpura
5%
Escherichia coli
5%
Erethism
5%
Binimetinib
5%
Anorexia
5%
Febrile Neutropenia
5%